Expression_NN
of_IN
Egr-1_NN
correlates_VBZ
with_IN
the_DT
transformed_VBN
phenotype_NN
and_CC
the_DT
type_NN
of_IN
viral_JJ
latency_NN
in_IN
EBV_NN
genome_NN
positive_JJ
lymphoid_JJ
cell_NN
lines_NNS
._.

In_IN
this_DT
paper_NN
we_PRP
have_VBP
investigated_VBN
the_DT
role_NN
of_IN
Egr-1_NN
in_IN
B_NN
cell_NN
growth_NN
regulation_NN
by_IN
examining_VBG
the_DT
gene_NN
expression_NN
in_IN
a_DT
panel_NN
of_IN
B_NN
cell_NN
lines_NNS
,_,
including_VBG
both_CC
EBV_NN
genome_NN
negative_JJ
and_CC
EBV_NN
carrying_VBG
cell_NN
lines_NNS
._.

Egr-1_NN
expression_NN
correlates_VBZ
with_IN
the_DT
cellular_JJ
phenotype_NN
and_CC
the_DT
specific_JJ
pattern_NN
of_IN
viral_JJ
latency_NN
established_VBN
within_IN
the_DT
individual_JJ
cell_NN
lines_NNS
._.

Thus_RB
,_,
constitutive_JJ
activation_NN
of_IN
Egr-1_NN
gene_NN
is_VBZ
invariably_RB
associated_VBN
with_IN
unrestricted_JJ
expression_NN
of_IN
viral_JJ
latent_JJ
genes_NNS
in_IN
all_DT
group_NN
III_CD
EBV_NN
genome_NN
carrying_VBG
cell_NN
lines_NNS
._.

In_IN
contrast_NN
,_,
Egr-1_NN
expression_NN
is_VBZ
abrogated_VBN
in_IN
group_NN
I_CD
Burkitt_NN
tumor_NN
cells_NNS
,_,
irrespective_JJ
of_IN
the_DT
EBV_NN
genome_NN
carrying_VBG
status_NN
._.

Activated_VBN
viral_JJ
gene_NN
expression_NN
associated_VBN
with_IN
phenotypic_JJ
conversion_NN
of_IN
group_NN
I_CD
cell_NN
lines_NNS
in_IN
to_TO
group_NN
II_CD
or_CC
III_CD
restores_VBZ
the_DT
Egr-1_NN
gene_NN
expression_NN
._.

Several_JJ
forms_NNS
of_IN
EGR-1_NN
protein_NN
are_VBP
found_VBN
within_IN
the_DT
different_JJ
groups_NNS
of_IN
cell_NN
lines_NNS
,_,
and_CC
the_DT
binding_VBG
activity_NN
to_TO
DNA_NN
consensus_NN
sequences_NNS
was_VBD
investigated_VBN
._.

Finally_RB
,_,
time_NN
course_NN
analysis_NN
of_IN
Egr-1_NN
expression_NN
during_IN
the_DT
early_JJ
steps_NNS
of_IN
EBV_NN
infection_NN
in_FW
vitro_FW
demonstrated_VBD
that_IN
Egr-1_NN
is_VBZ
upregulated_VBN
within_IN
minutes_NNS
from_IN
the_DT
initial_JJ
interaction_NN
with_IN
the_DT
B_NN
lymphocyte_NN
._.

